About
Experienced Biologist and Business Development Representative at Halia Therapeutics…
Activity
-
Exciting news in the fight against neurodegenerative diseases! Halia Therapeutics and Biolexis Therapeutics have teamed up to develop a new drug…
Exciting news in the fight against neurodegenerative diseases! Halia Therapeutics and Biolexis Therapeutics have teamed up to develop a new drug…
Liked by Taylor Avei
-
This is an exciting collaboration to be involved in. By combining our cutting-edge MolecuLern process with Halia’s expertise in chronic inflammation,…
This is an exciting collaboration to be involved in. By combining our cutting-edge MolecuLern process with Halia’s expertise in chronic inflammation,…
Liked by Taylor Avei
-
This has been a very productive and effective collaboration with two companies I am honored to have been a founder of. The AI-driven Moleculern…
This has been a very productive and effective collaboration with two companies I am honored to have been a founder of. The AI-driven Moleculern…
Liked by Taylor Avei
Experience & Education
More activity by Taylor
-
Congratulations to CEO, Dr. David J. Bearss, on being recognized for his exceptional contributions to the pharmaceutical industry! His dedication and…
Congratulations to CEO, Dr. David J. Bearss, on being recognized for his exceptional contributions to the pharmaceutical industry! His dedication and…
Liked by Taylor Avei
-
A fascinating new publication in Nature connects inflammation to longevity and healthspan in animals. Relatively few genes and gene products have…
A fascinating new publication in Nature connects inflammation to longevity and healthspan in animals. Relatively few genes and gene products have…
Liked by Taylor Avei
-
We are excited to see how our new strategy to target neuroinflammation can make a difference in Parkinson's and other neurodegenerative diseases.
We are excited to see how our new strategy to target neuroinflammation can make a difference in Parkinson's and other neurodegenerative diseases.
Liked by Taylor Avei
-
Great leaders know when to walk away from power, and have the guts & character to do it.
Great leaders know when to walk away from power, and have the guts & character to do it.
Liked by Taylor Avei
-
I'm happy to share that I'm starting a new position as Manager at Connor Group! I'm very grateful for the sharp individuals I get to work with at…
I'm happy to share that I'm starting a new position as Manager at Connor Group! I'm very grateful for the sharp individuals I get to work with at…
Liked by Taylor Avei
-
Did you know that Alzheimer's disease doesn't always start with memory loss? This article discusses the five different types of atypical Alzheimer's…
Did you know that Alzheimer's disease doesn't always start with memory loss? This article discusses the five different types of atypical Alzheimer's…
Liked by Taylor Avei
-
Having two copies of the APOE4 gene is a strong risk factor for Alzheimer's disease, but it does not mean you will get it for sure. Estimates vary…
Having two copies of the APOE4 gene is a strong risk factor for Alzheimer's disease, but it does not mean you will get it for sure. Estimates vary…
Liked by Taylor Avei
-
Venture Capital Podcast revealed its Founder 100 list for Utah, and several BioUtah members made the list. The Founder 100 list recognizes the top…
Venture Capital Podcast revealed its Founder 100 list for Utah, and several BioUtah members made the list. The Founder 100 list recognizes the top…
Liked by Taylor Avei
-
A new study has reported that chronic inflammation in young adulthood predicts reduced cognitive function later in life. Chronic inflammation plays a…
A new study has reported that chronic inflammation in young adulthood predicts reduced cognitive function later in life. Chronic inflammation plays a…
Liked by Taylor Avei
-
Halia at the Forefront of Chronic Inflammation Treatment! In a recent interview with Joe Petroziello of Pharmaceutical Executive, CEO, Dr. David…
Halia at the Forefront of Chronic Inflammation Treatment! In a recent interview with Joe Petroziello of Pharmaceutical Executive, CEO, Dr. David…
Liked by Taylor Avei
-
The FDA clearance of Leqembi and the recent endorsement of donanemab by an independent panel of advisors to the FDA point to the importance of early…
The FDA clearance of Leqembi and the recent endorsement of donanemab by an independent panel of advisors to the FDA point to the importance of early…
Liked by Taylor Avei
-
John Kauwe’s company, Halia Therapeutics, Inc., is launching a phase I trial this summer using the target identified by his 2013 #CCAD grant and the…
John Kauwe’s company, Halia Therapeutics, Inc., is launching a phase I trial this summer using the target identified by his 2013 #CCAD grant and the…
Liked by Taylor Avei
-
Every pitch can make or break a deal. But not all decks are created equal. Here are the only 10 slides you need in your pitch, according to Guy…
Every pitch can make or break a deal. But not all decks are created equal. Here are the only 10 slides you need in your pitch, according to Guy…
Liked by Taylor Avei
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More